Cairo. 12 November 2022. By Invitation @ The Pyramids
Global Impact Summit.
Where impact, finance and technology converge.
Featured Speakers
-
Amani Hajir
Development & Fundraising Advisor @ Luminus Life+
-
Ayman Abdellatif
Managing Director of Egypt @ Honoris United Universities
-
Ayman Bazaraa
Co-Founder @ Sprints
-
Ayman Ismail
Associate Professor and Abdul Latif Jameel Endowed Chair of Entrepreneurship @ The American University in Cairo
-
Con O'Donnell
Head of Digital Products @ Nahdet Misr
-
Dalia Ibrahim
CEO @ Nahdet Misr Publishing Group & Founder 2 EdVentures
-
Krishnan Gopi
Group Chief Disruption Officer @ GEMS Education
-
Maged Harby
General Manager @ EdVentures
-
Mike Damiano
Director, National Education Initiatives @ Coursera
-
Mohammed Husamaddin
Vice President, Portfolio Dev & Marketing @ Naseej
-
Nadine Hachach Haram
CEO and Founder @ Proximie
-
Rafeh Saleh
Founding Partner @ Cubit Ventures
-
Stavros Yiannouka
CEO @ WISE, Qatar Foundation
-
Tarek Nour El Deen
Co-Founder & CEO @ OTO Courses
Presenting Partners
Education
Imagining a world where everyone of earth has equal access to the future.
Education, training and the world of work have been significantly impacted by the COVID-19 pandemic and the role of digital will be core to the future of learning - from early childhood, K12, higher education through to workforce upskilling.
We are seeing full spectrum innovation from digital content, online learning, advanced technology from AI to robotics and, web3 to the metaverse into language learning, tutoring, assessment, up-skilling and beyond.
Capital for innovation is flowing into the sector as traditional education systems urgently seek digital solutions right across the learner lifecycle and new models, approaches and solutions emerge to build new competitive landscapes.
Health
Innovation and technology is accelerating and fundamentally reshaping health and wellness to create more resilient, efficient, and equitable healthcare systems to keep populations happy, healthy and deliver the best care.
BioPharma research innovation led by AI driven drug discovery, synthetic biology and lab automation. Enhanced clinical development through data aggregation, data science and decentralized trial technology.
New approaches to wellness, preventative and pre-symptomatic technology with innovation in screening, imaging, diagnosis and ecosystem connectivity.
Towards a new approach to treatment and care including tele-health, digital therapeutics, the digital operating room, rehabilitation and chronic care.